Stay updated on Inhaled Imatinib for PAH Clinical Trial
Sign up to get notified when there's something new on the Inhaled Imatinib for PAH Clinical Trial page.

Latest updates to the Inhaled Imatinib for PAH Clinical Trial page
- Check3 days agoChange DetectedThe site's footer revision label changed from v3.7.2 to v3.8.0 while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedA sitewide NIH notice about terminology changes appears above the page, which continues to show a 403 Forbidden error. The footer revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check31 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check45 days agoChange DetectedAccess to the study record page is blocked by a 403 Forbidden error, replacing the detailed trial information with an error screen. The page now shows a minimal header and a Home link instead of study details and locations.SummaryDifference17%

- Check52 days agoChange DetectedThe page shows a new Revision: v3.7.0, replacing Revision: v3.6.6, indicating a deployment or update of the page's underlying version.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page's revision tag was updated to v3.6.6, replacing the previous v3.6.5.SummaryDifference0.0%

Stay in the know with updates to Inhaled Imatinib for PAH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled Imatinib for PAH Clinical Trial page.